Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes. Groothof D, Vogelpohl FA, Bakker SJL. N Engl J Med 2021;385:2106.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Groothof D, Vogelpohl FA, Bakker SJL. Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes. N Engl J Med 2021;385:2106.
PMID: 34818490